This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

IPA Guidelines for relationships with Industry

As approved by the EC on May 15th, 2014

IPA Policies regarding donations from External Organizations

Principles

  • IPA vision and values must drive any proposed relationships with donors
  • Funding relationships must preserve and promote trust in IPA.
  • Funding relationships must preserve IPA control over all proposed activities.
  • Any IPA activity must promote children’s health and /or the capacity of pediatricians to improve children’s health.
  • IPA will not involve itself in the endorsement or marketing of products.
  • IPA activities should be funded from multiple sources whenever possible.
  • Member societies must be accountable to explicit ethical standards which are consistent with IPA policy.

Policy

  1. Grants and/or donations may be accepted for general or specific purposes. Discussion and written agreement with the donor are essential to ensure that grants and/or donations will be used appropriately and ethically for the purpose for which they are given. If they are given to support ethical research, IPA reserves the right to publish actual results in appropriate publications without censorship or influence from donors.
  2. Grant and/or donations will be acknowledged in the Triennial Report of the Executive Director and President.
  3. Grants and/or donations will not be accepted from organizations or industries directly engaged in: 

    Production, distribution, advertising, marketing or sponsorship of:
    − Tobacco and tobacco products
    − Alcohol production for consumption
    − Arms production

    Negative practices including:
    − Violations of the International Code of Marketing of Breast-milk Substitutes or other unethical marketing practices
    − Exploitation of children or child labor
    − Discriminatory business practices

IPA Policy on Infant Formula Manufacturers

In addition to the general principles stated above regarding grants and/or donations from external organizations, IPA restates its earlier position: “IPA has for many years strongly advocated breastfeeding for babies worldwide and will continue to do so.”

IPA fully supports the WHO International Code on the Marketing of Breast Milk Substitutes and its subsequent biannual amendments of the World Health Assembly.

To this end and in full compliance with the WHO International Code on the Marketing of Breast Milk Substitutes (articles 7.2 and 7.4):

  • Information provided by manufacturers and distributors to health professionals regarding products should be restricted to scientific and factual matters,
  • Such information should not imply or create a belief that bottle-feeding is equivalent or superior to breastfeeding.

IPA Policy on the ethical conduct of congresses, workshops, seminars etc…

  1. Commercial exhibits must be for educational purposes only and open only to registered delegates. Examples of products include:
    - pharmaceuticals,
    - technical equipments,
    - educational tools.

  2. There should be clear acknowledgment in the exhibition area by Milk substitute manufacturing companies about the superiority of breastfeeding.
  3. Samples distribution of infant formula or other similar products is not allowed within the exhibition area.
  4. There will be a clear acknowledgment of all corporate sponsorships in Congress materials, without use of product names or logos or awards.
  5. Any conflicts of interest must be disclosed in written documentation for:
    - chairs of sessions,
    - speakers at sessions,
    - discussants at sessions (verbally, when appropriate),
    - IPA programs and publications.

    Examples of conflict of interest include:
    - employment of self or close family members in commercial organizations relevant to the content of the session,
    - funding of research by commercial organizations
    - funding of delegate's registration/travel/accommodation at the meeting

  6. The IPA/Congress logo will be the only logo displayed on delegates’ kits, banners and scientific session material.
  7. IPA/Congress promotional material will be displayed in a prominent manner. Any commercial material must be secondary and much less prominent.
  8. The use of commercial promotional material on audio-visual aids for scientific sessions is not permitted.
  9. Research presented at the Congress must be conducted in an ethical manner and, whenever possible, institutional ethical review approval must be documented. In the case of multinational research, all countries involved must give approval.
  10. IPA will provide space in the Congress venue for promotion of breast-feeding.
  11. Congress organizers must present a written document to IPA stating that their Congress will be conducted with strict adherence to IPA ethical standards as set forth in this document.
  12. Exhibitors and/or sponsors should sign a compliance form to make sure that the IPA Guidelines are strictly followed.

 

IPA Policy regarding individual ethical responsibility at scientific meetings.

  1. Accepting financial incentives to purchase products is not permitted.
  2. Acceptance of excessive gifts for delegates is not acceptable.
  3. Acceptance of free samples of drugs and other products is not acceptable.

IPA Policy on education in ethical values

  1. IPA promotes the learning of ethical values and principles, particularly in relation to child health, beginning in undergraduate training and progressing through the continuum of medical education.
  2. The ethical conduct of the IPA Congresses/Workshops/Seminars is a practical ethical role model. Specific sessions on ethical issues may also be included in the program.
  3. IPA makes available to member societies emerging information on contemporary ethical issues.